National HealthCare Competitors

HCA Healthcare (NYSE:HCA) and National HealthCare (NYSEAMERICAN:NHC) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations and earnings.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for HCA Healthcare and National HealthCare, as provided by MarketBeat.com.

HCA Healthcare presently has a consensus target price of $171.9375, indicating a potential downside of 1.28%. Given HCA Healthcare's higher probable upside, research analysts clearly believe HCA Healthcare is more favorable than National HealthCare.

Volatility & Risk

HCA Healthcare has a beta of 1.58, indicating that its share price is 58% more volatile than the S&P 500. Comparatively, National HealthCare has a beta of 0.19, indicating that its share price is 81% less volatile than the S&P 500.

Insider & Institutional Ownership

68.7% of HCA Healthcare shares are held by institutional investors. Comparatively, 44.2% of National HealthCare shares are held by institutional investors. 1.8% of HCA Healthcare shares are held by insiders. Comparatively, 13.1% of National HealthCare shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares HCA Healthcare and National HealthCare's net margins, return on equity and return on assets.

Earnings & Valuation

This table compares HCA Healthcare and National HealthCare's revenue, earnings per share (EPS) and valuation.

HCA Healthcare has higher revenue and earnings than National HealthCare.

Summary

HCA Healthcare beats National HealthCare on 10 of the 12 factors compared between the two stocks.

National HealthCare (NYSEAMERICAN:NHC) and Alcon (NYSE:ALC) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk.

Volatility and Risk

National HealthCare has a beta of 0.19, meaning that its share price is 81% less volatile than the S&P 500. Comparatively, Alcon has a beta of 0.6, meaning that its share price is 40% less volatile than the S&P 500.

Valuation & Earnings

This table compares National HealthCare and Alcon's gross revenue, earnings per share and valuation.

National HealthCare has higher earnings, but lower revenue than Alcon.

Institutional & Insider Ownership

44.2% of National HealthCare shares are owned by institutional investors. Comparatively, 46.5% of Alcon shares are owned by institutional investors. 13.1% of National HealthCare shares are owned by insiders. Comparatively, 1.5% of Alcon shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Analyst Ratings

This is a summary of current ratings for National HealthCare and Alcon, as provided by MarketBeat.com.

Alcon has a consensus price target of $65.80, indicating a potential downside of 5.83%. Given Alcon's higher possible upside, analysts clearly believe Alcon is more favorable than National HealthCare.

Profitability

This table compares National HealthCare and Alcon's net margins, return on equity and return on assets.

Universal Health Services (NYSE:UHS) and National HealthCare (NYSEAMERICAN:NHC) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, valuation and profitability.

Analyst Recommendations

This is a breakdown of current recommendations for Universal Health Services and National HealthCare, as reported by MarketBeat.

Universal Health Services presently has a consensus price target of $138.70, suggesting a potential upside of 9.15%. Given Universal Health Services' higher probable upside, analysts plainly believe Universal Health Services is more favorable than National HealthCare.

Profitability

This table compares Universal Health Services and National HealthCare's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Universal Health Services and National HealthCare's top-line revenue, earnings per share and valuation.

Universal Health Services has higher revenue and earnings than National HealthCare.

Volatility and Risk

Universal Health Services has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500. Comparatively, National HealthCare has a beta of 0.19, indicating that its stock price is 81% less volatile than the S&P 500.

Insider & Institutional Ownership

82.3% of Universal Health Services shares are owned by institutional investors. Comparatively, 44.2% of National HealthCare shares are owned by institutional investors. 12.6% of Universal Health Services shares are owned by insiders. Comparatively, 13.1% of National HealthCare shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Universal Health Services beats National HealthCare on 9 of the 12 factors compared between the two stocks.

National HealthCare (NYSEAMERICAN:NHC) and Tenet Healthcare (NYSE:THC) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability and earnings.

Profitability

This table compares National HealthCare and Tenet Healthcare's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current ratings and recommmendations for National HealthCare and Tenet Healthcare, as reported by MarketBeat.

Tenet Healthcare has a consensus target price of $43.8824, suggesting a potential downside of 17.00%. Given Tenet Healthcare's higher probable upside, analysts plainly believe Tenet Healthcare is more favorable than National HealthCare.

Institutional & Insider Ownership

44.2% of National HealthCare shares are held by institutional investors. Comparatively, 93.1% of Tenet Healthcare shares are held by institutional investors. 13.1% of National HealthCare shares are held by insiders. Comparatively, 1.7% of Tenet Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Risk and Volatility

National HealthCare has a beta of 0.19, meaning that its stock price is 81% less volatile than the S&P 500. Comparatively, Tenet Healthcare has a beta of 2.66, meaning that its stock price is 166% more volatile than the S&P 500.

Valuation & Earnings

This table compares National HealthCare and Tenet Healthcare's revenue, earnings per share and valuation.

National HealthCare has higher earnings, but lower revenue than Tenet Healthcare.

Acadia Healthcare (NASDAQ:ACHC) and National HealthCare (NYSEAMERICAN:NHC) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, valuation, analyst recommendations, profitability and risk.

Insider & Institutional Ownership

44.2% of National HealthCare shares are owned by institutional investors. 1.6% of Acadia Healthcare shares are owned by insiders. Comparatively, 13.1% of National HealthCare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Risk and Volatility

Acadia Healthcare has a beta of 1.49, meaning that its stock price is 49% more volatile than the S&P 500. Comparatively, National HealthCare has a beta of 0.19, meaning that its stock price is 81% less volatile than the S&P 500.

Profitability

This table compares Acadia Healthcare and National HealthCare's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Acadia Healthcare and National HealthCare, as provided by MarketBeat.com.

Acadia Healthcare presently has a consensus target price of $48.2222, suggesting a potential downside of 13.05%. Given Acadia Healthcare's higher possible upside, equities analysts clearly believe Acadia Healthcare is more favorable than National HealthCare.

Valuation and Earnings

This table compares Acadia Healthcare and National HealthCare's revenue, earnings per share and valuation.

Acadia Healthcare has higher revenue and earnings than National HealthCare.

Summary

Acadia Healthcare beats National HealthCare on 9 of the 13 factors compared between the two stocks.

The Ensign Group (NASDAQ:ENSG) and National HealthCare (NYSEAMERICAN:NHC) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, analyst recommendations, institutional ownership, earnings and profitability.

Insider and Institutional Ownership

78.6% of The Ensign Group shares are owned by institutional investors. Comparatively, 44.2% of National HealthCare shares are owned by institutional investors. 6.8% of The Ensign Group shares are owned by company insiders. Comparatively, 13.1% of National HealthCare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent ratings and price targets for The Ensign Group and National HealthCare, as provided by MarketBeat.com.

The Ensign Group presently has a consensus price target of $63.80, indicating a potential downside of 23.24%. Given The Ensign Group's higher probable upside, research analysts clearly believe The Ensign Group is more favorable than National HealthCare.

Earnings and Valuation

This table compares The Ensign Group and National HealthCare's top-line revenue, earnings per share (EPS) and valuation.

The Ensign Group has higher revenue and earnings than National HealthCare.

Dividends

The Ensign Group pays an annual dividend of $0.21 per share and has a dividend yield of 0.3%. National HealthCare pays an annual dividend of $2.08 per share and has a dividend yield of 3.0%. The Ensign Group pays out 10.0% of its earnings in the form of a dividend. The Ensign Group has raised its dividend for 1 consecutive years and National HealthCare has raised its dividend for 1 consecutive years.

Volatility & Risk

The Ensign Group has a beta of 1.05, suggesting that its share price is 5% more volatile than the S&P 500. Comparatively, National HealthCare has a beta of 0.19, suggesting that its share price is 81% less volatile than the S&P 500.

Profitability

This table compares The Ensign Group and National HealthCare's net margins, return on equity and return on assets.

Summary

The Ensign Group beats National HealthCare on 10 of the 14 factors compared between the two stocks.